AACR 2017 - IMODI initiative : a novel holistic and integrative approach with patient-derived tumor models against pancreatic cancer
Ariana Pharmaceuticals, Paris; Biofortis, Saint-Herblain; CTI-BIOTECH, Meyzieu;Modul-Bio, Marseille; Oncodesign, Dijon ; OncoMedics, Limoges; Ipsen Innovation, Les Ulis; Pierre Fabre Research Institut, St-Julien-en-Genevois; Sanofi, Vitry-sur-Seine; Centre Léon Bérard, Lyon; INSERM U1068, Marseille; Synergie Lyon Cancer, Lyon; CIPREVO, Antony (France)